Development deals

Genentech scraps $2B cell therapy pact with Adaptive

The January 2019 pact with Adaptive Biotech was meant to see Genentech develop personalized cancer therapies based on Adaptive’s T-cell receptor tech.

Darren Incorvaia Aug 18, 2025 2:40pm

Lilly crafts deal with UK biotech for new ALS antibodies

Jan 9, 2025 10:55am

Close-up picture of Swiss cheese on cutting board

Roche's Chugai inks Swiss ADC deal potentially worth over $780M

Jan 8, 2025 8:00am

Hundred dollar bills wrapped with a red bow under a Christmas tree

Candid unwraps 3 collabs to develop new T-cell engagers

Dec 16, 2024 11:59am

Hand reaching for juice on grocery store shelf

Genmab buys 2nd antibody from Scancell in deal worth up to $630M

Dec 4, 2024 11:55am

GSK offers Rgenta up to $500M biobucks per target in RNA deal

Dec 4, 2024 8:00am